Technology | July 30, 2012

Emerge Nuclear Software Can Diagnose Appropriate Use

Software can help determine when perfusion imaging is needed, even without obvious symptoms

July 30, 2012 — Emerge Clinical Solutions, a creator of clinical decision support software, announced nuclear myocardial perfusion imaging (MPI) appropriateness update 3.1 that allows for diagnosis of both symptomatic and asymptomatic conditions.

In medicine, patients are simpler to diagnose when they show clear symptoms or signs of disease or injury. However, often an illness is asymptomatic, which means it is present but does not demonstrate obvious symptoms. Asymptomatic patients can be a challenge since asymptomatic illnesses are particularly difficult to discover and diagnose, especially in early stages.

Emerge’s real-time clinical decision solution helps doctors increase diagnosis efficiency and accuracy by filtering comprehensive patient data and history through the company’s rules engine and patented algorithms. The software has been proven to increase identification of certain cardiac diseases by as much as 300 percent. The Emerge rules engine performs more than 8,000 calculations in seconds to help doctors elect the most appropriate testing and procedures and choose a care path.

“Asymptomatic conditions are difficult to uncover, but they are no less threatening to a patient’s health. Emerge’s agnostic software can process data exponentially faster than any human brain, so it helps doctors find the right solution quickly. Time is of the essence when it comes to cardiology, and we help doctors decide the best care path without losing time on unnecessary testing,” said Emerge CEO Scott Finfer.

Cardiologists are often overwhelmed with the volume of information and data to consider when evaluating patients. Emerge’s software simplifies the decision process and merges seamlessly with any electronic medical record (EMR), integrating in real-time. Its algorithms utilize appropriate use criteria and guidelines from the American College of Cardiology (ACC), American Health Association (AHA) and Heart Rhythm Society (HRS). The software exceeds stage 1 meaningful use requirements, as well as the proposed requirements of stages 2 and 3.

For more information: www.emergecds.com

Related Content

New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
News | Remote Viewing Systems | June 14, 2018
International Medical Solutions (IMS) recently announced that the American College of Radiology (ACR) added IMS'...
Wake Radiology Launches First Installation of EnvoyAI Platform
News | Artificial Intelligence | June 13, 2018
Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Zebra Medical Vision Unveils AI-Based Chest X-ray Research
News | Artificial Intelligence | June 08, 2018
June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future
Konica Minolta Launches AeroRemote Insights for Digital Radiography
Technology | Analytics Software | June 07, 2018
Konica Minolta Healthcare Americas Inc. announced the release of AeroRemote Insights, a cloud-based, business...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Overlay Init